Steroid responsive chorea in Moyamoya disease: illustrative cases
Objective: To report the rapid reduction of disabling chorea in two cases of pediatric Moyamoya disease with pulse steroid therapy. Background: The common clinical presentation…Sydenham’s chorea: Clinical features and treatment outcome
Objective: To study the clinical features, investigations and treatment outcome in Sydenham’s chorea patients. Background: Sydenham’s chorea is one of the major clinical manifestations of…Huntington Disease-Like 2: A Case Presentation and Review of the Literature
Objective: To present a case of Huntington Disease-Like 2 (HDL2). HDL2 is rare and phenotypically similar to Huntington’s Disease (HD). However the gene, chromosome, and…Genetic diagnosis of Chorea-acanthocytosis using whole exome sequencing revealed novel VPS13A Gene mutation
Objective: We hereby report a patient who is genetically confirmed Chorea-acanthocytosis (ChAc). Background: ChAc is a rare autosomal recessive genetic disorder caused by mutation of…Gut problems in Huntington’s disease? Evidence for a leaky gut in the R6/2 mouse model of HD
Objective: This project aims to investigate how leaky the gut is in HD, why the gut is leaky, and how this relates to HD symptoms.…An adult type Niemann-Pick disease type C family: Huntington’s disease-like expression
Objective: We present a family with Niemann-Pick disease type C (NPC) expressing Huntington's disease-like involuntary movements. The process for the diagnosis may be a good…Chorea-acanthocytosis: Challenges in early diagnosis and excellent treatment response to Deep Brain Stimulation (DBS) – a case report
Objective: To describe diagnostic challenges and the response to DBS in a patient with genetically confirmed Chorea-acanthocytosis (ChAc). Background: At the age of 20 during…An updated flow chart for the evaluation of chorea
Objective: The aim of this poster is to provide a tool to facilitate diagnosis of chorea. This flow chart has been presented at previous MDS…Acute hypertensive crisis with myoclonic movements induced by withdrawal of intrathecal combined clonidine and morphine administration
Objective: Clonidine is a centrally acting alpha(2)-agonist antihypertensive drug used for opioid/alcohol withdrawal and for intrathecal administration in the treatment of chronic neuropathic pain. Cases…The distinct pattern of movement disorders in Caspr2 and LGI1 antibody associated autoimmune encephalitis
Objective: The aim of this study was (1) to investigate the prevalence of movement disorders in a large cohort of patients with encephalitis with LGI1…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.